Dec 07 2025
JHX Deadline: JHX Investors with Losses in Excess of $100K Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FCX
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DeFi Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DEFT
CPTN DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CPTN
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OWL
1 Nvidia-Backed Artificial Intelligence Stock to Buy Hand Over Fist in 2026
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARE
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Drilling hits wide zone of mineralisation in new area well outside resource
Prediction: This Stock Will Be the Biggest Quantum Computing Winner of 2026
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
Here's Why Alphabet Is the Best-Performing "Magnificent Seven" Stock in 2025 (and Why It Has Room to Run in 2026)
2 High-Yield Dividend ETFs to Buy Today
Can Peloton (PTON) Stock Rebound in 2026?
Why One Hedge Fund Just Put $246 Million Into This Life Sciences Supplier
Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
MLTX DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
My Surprising Top "Magnificent Seven" Stock Pick for 2026
Snowflake Shares Melt. Is It Time to Buy the Stock on the Dip?
MRX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Marex Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - MRX
Экспонаты Blokees на выставке CCXP25 в Бразилии -- мировая премьера нового продукта Saint Seiya
Blokees auf der CCXP25 in Brasilien: Weltpremiere des neuen Produkts Saint Seiya
Victory Fighting League CEO on Climbing MMA Popularity, TKO Rally
S&P 500: Sell Strength (Technical Analysis)
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
Netflix co-CEO reportedly discussed Warner Bros. deal with Trump
Why One Fund Just Bet $64 Million on a Healthcare Stock Down 63% This Past Year
Gentherm Stock Down 60% Since 2022 — But One Hedge Fund Just Bought 431,072 Shares
Where Will Quantum Computing Stock Be in 1 Year?
SL Green chief expects thriving NYC office market to continue — even under Mamdani
Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Better Artificial Intelligence Stock: Palantir Technologies vs. Nvidia
Evaluating EPD Stock's Actual Performance
Why One Hedge Fund Has a $28 Million Bet on This Electronics Manufacturing Stock
Replicor publishes data from its compassionate access program in HBV/HDV
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
1 Growth Stock Down 27% to Buy Right Now
Why Norwegian Cruise Lines Fell Overboard in November
Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs Transcript
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - JYD
This Artificial Intelligence (AI) Infrastructure Stock Could Be the Nvidia of 2026
AVTR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
DXCM DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
Macquarie Value Fund Q3 2025 Sales And Purchases
Macquarie Value Fund Q3 2025 Contributors And Detractors
This Hedge Fund's Materion Stake Tops $38 Million as Earnings Strength Pushes Shares Near Record Highs
Fed Rate Decision, Oracle, Costco, Broadcom, and More Stocks to Watch
Prologis announces redemption of 3.00% Notes due 2026
Looking for Top ETFs? Here's One to Consider Now.
Silver (XAG) Forecast: Price Prediction Points Higher if Fed Confirms 2026 Rate Cuts
Hedge Fund Buys 622,500 Knowles Shares as Stock Outperforms S&P 500 — Should You?
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?
Think Palantir Stock Is Expensive? This 1 Chart Might Change Your Mind.
1 Quantum Computing Stock to Buy Hand Over Fist in December
Arons: 2026 Looks "Pretty Good," Likes AMZN, LULU, META
Vertex Stock: Why One Fund Lifted Its $94.3 Million Position Even as Shares Sank
Incyte Gets FDA Breakthrough Therapy Fast Track For Rare Blood Cancer Drug
Costco's Trump Lawsuit and Q1 2026 Earnings: What Investors Need to Watch
Warren Buffett Is Sending a Clear Warning As 2026 Approaches: 3 Things Investors Should Do
Apple's executive shake-up continues.
Why One Fund Just Put $23.5 Million Into Champion Homes Despite an 18% Stock Slide
UiPath Shares Surge. Is It Too Late to Buy the Stock?
2 Things Every GE Vernova Investor Needs to Know
Forget Medtronic, Buy This Healthcare Stock Instead
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
Centuri Stock Up 18% This Year: What a New $17 Million Position Signals for Investors
10 Energy Stocks to Buy Right Now
3 Top Stocks to Buy for 2026
BTDR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitdeer Technologies Group Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
FDG: One Of The Few Outperformers In 2025
3 No-Brainer Growth Stocks to Buy for 2026 With $100 Right Now
EPU: A Mining ETF With A Large-Cap Bank
Evaluating VRT Stock's Actual Performance
Why One Investor Just Doubled Down on Clearwater Analytics Stock with a $45 Million Position
Oracle: Why This Selloff Looks Like An Early Christmas Gift
Apple stock under pressure after major executive departures: what it means for AAPL's AI roadmap
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)
WPP DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages WPP plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - WPP
3 Incredible Growth Stocks to Buy Now
Down 27%, Should You Buy Adobe Stock Before Dec. 10?
Financial Institutions Is Still Worth Banking On
'Trump accounts,' explained: Who qualifies, how they work and when you can claim
Netflix Stock Up 13%. Why $82.7 Billion $WBD Buy Makes $NFLX A Sell
Better Buy for 2026: ExxonMobil or Chevron?
Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript
Value Fund Cuts nCino Stake After $152 Million Quarter: What Long-Term Investors Should Know
Coinbase starts onboarding users again in India, plans for fiat on-ramp next year
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET
American Electric Power: Unmatched Reach Make It A Buy
The Merger Fund Q3 2025 Contributors And Detractors
Brookfield, GIC near binding offer for National Storage, Bloomberg News reports
As Growth Accelerates, Is It Time to Buy CrowdStrike Stock?
Cellnex Telecom Is Now A 'Strong Buy'
Exxon Mobil's 43 Year Dividend Streak Looks Secure Despite Falling Earnings
3 Yield-Producing ETFs with Real Staying Power
'PROJECT TALON': Northrop Grumman reveals new 'autonomous wingman'
1 Vanguard ETF I'm Buying in 2026 and Holding Forever
NDMO: I Generally Get Cautious After Sharp Pops Higher (Rating Downgrade)
Risk Disclosure: Trading Contracts for Difference on margin carries a high level of risk, and may not be suitable for all investors. By trading Contracts for Difference, you could sustain a loss of all your deposited funds. BCR makes no recommendations as to the merits of any financial product referred to on our website, emails, or related material(s). The information contained on our website, emails, or related material(s) does not take into consideration prospective clients' trading objectives, financial situations, or investment needs. Before deciding to trade the Contracts for Difference offered by BCR, please ensure that you have read our Product Disclosure Statement ,  Financial Services Guide ,  Target Market Determination and have sought independent professional financial advice to ensure you fully understand the risk involved before trading.
"BCR" is a registered business name of Bacera Co Pty Ltd, Australian Company Number 130 877 137, Australian Financial Services Licence Number 328794.
Business Address: Suite 3, Level 18, 201 Elizabeth Street, SYDNEY NSW 2000 | Registered Address: Level 1, 6-10 O'Connell Street, SYDNEY NSW 2000
The information on this site is not directed at residents of any particular country outside of Australia and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.